Psychostimulant addiction is an important, relapsing condition for which there is no effective pharmacological treatment. Countering this problem requires an understanding of the specific risk factors that predispose individuals to initial misuse of these drugs. Healthy individuals display marked individual differences in emotional, behavioral and brain responses to low and moderate doses of stimulant drugs. These betweenperson differences have been most often studied using personality measures of sensation seeking. However, a growing body of work in healthy adults indicates potentially unique sources of variance in these responses that are related to four dissociable personality domains: extraversion, fearlessness, impulsivity and absorption. These four domains are empirically dissociable and can serve as endophenotypic markers of dopamine, norepinephrine and serotonin function in healthy individuals. The relationship between normal variation in these traits and the pharmacological effects of these drugs is here proposed as a framework for better understanding the specific sources of between-person variation in stimulant drug effects on mood, behavior and brain responses in healthy humans. 
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Individual differences in drug effects and monoamine systems
Psychostimulant drugs temporarily increase positive mood, energy, alertness, attention and cardiovascular activity. These medications are prescribed as part of the medical management of ADD, ADHD, narcolepsy and treatment-resistant depression. Unfortunately, these drugs are also commonly misused. For example, up to 30% of college students in the US have been reported to use psychostimulant drugs for recreation and cognitive enhancement [1] . For unknown reasons, a percentage of these individuals graduate to regular use -leaving them vulnerable to the legal, health and occupational consequences of drug misuse. Understanding the effects of these stimulants in young people and between-person differences in drug response is critical for predicting their effects on particular individuals and prospectively assessing the risk for conversion to regular use and dependence. The potential clinical utility of considering personality as a risk factor for addiction is underscored by the success of personality-targeted psychoeducational interventions against substance use disorders in adolescents (e.g., [2, 3] ).
Acute responses to psychostimulant drugs in humans can be investigated experimentally using well-established methods of behavioral pharmacology and neuroimaging. The typical approach involves administration of low to moderate doses of FDA-approved psychostimulants such as d-amphetamine to medically healthy volunteers in a double blind, placebo-controlled design in standard lab settings. This approach provides information on the acute effects of psychostimulants on mood, brain and behavior along with between-person differences in the drug response.
Such studies have revealed substantial between-person variation in acute psychostimulant effects. These effects have been most often investigated using trait measures of sensation seeking, a personality domain that encompasses a range of exploratory tendencies including exploration of novel environments, disinhibition in social settings, preference for dangerous excitement and low tolerance for boredom. Sensation seeking is a multi-dimensional composite of the proclivity toward active approach to social, novel and occasionally dangerous cues coupled with an active avoidance of boring, albeit safe, alternatives. This domain relates to a broad range of between-person differences in both the approach and exploration of drugs with abuse potential and the experience of those drugs once consumed. Notably, sensation seeking is often the sole personality domain assessed in drug effect studies.
This focus on sensation seeking has strengths and limitations. Strengths include the ability to measure a rich array of behavioral and emotional tendencies relevant to drug responses in a single, composite measure. However, this 
